FDA Declines to Approve Acer Therapeutics ' Treatment for Rare Genetic Disorder FDA Declines to Approve Acer Therapeutics ' Treatment for Rare Genetic Disorder

Acer Therapeutics Inc said on Tuesday its treatment for a severe, rare genetic disorder that can cause blood vessels to fatally rupture was declined approval from the U.S. Food and Drug Administration.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news